Form D · Pharmaceuticals
Moleculin, LLC
Houston, TX · CIK 0001514912
Offering snapshot reported Oct 16, 2014 · SEC filing
- Reported sold
- $1.38M Offering amount: $2M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 14, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$782,783 → $1,382,783
- Reported investors24 → 36
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2014 | Amendment | $1,382,783 | $600,000vs Oct 2, 2014 | 36 | SEC filing |
| Oct 2, 2014 | Amendment | $782,783 | $99,799vs May 23, 2014 | 24 | SEC filing |
| May 23, 2014 | Amendment | $682,984 | $191,974vs May 16, 2014 | 21 | SEC filing |
| May 16, 2014 | Initial | $491,010 | No comparison | 13 | SEC filing |
| Jun 14, 2013 | Amendment | $2,019,116 | $491,651vs Apr 24, 2013 | 64 | SEC filing |
| May 21, 2013 | Amendment | $1,877,657 | $350,192vs Apr 24, 2013 | 66 | SEC filing |
| Apr 24, 2013 | Initial | $1,527,465 | No comparison | 59 | SEC filing |
| Aug 22, 2012 | Initial | $3,184,757 | No comparison | 61 | SEC filing |
| Dec 14, 2011 | Amendment | $4,490,309 | $3,325,309vs Mar 11, 2011 | 8 | SEC filing |
| Mar 11, 2011 | Initial | $1,165,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $60K
- Form D file number
- 021-217566
Source: Form D, filed Oct 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lori H Bisson | Director, Executive |
| Michael Clinard | Director |
| Robert Conrad | Director |
| Stephen Drake | Director |
| J. George Gumulka | Director |
| Walter V Klemp | Director, Executive |
| Donald Picker | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1225 North Loop West Suite 725
Houston, TX, 77008
Houston, TX, 77008